Clinical data from a unique case of SARS-CoV-2 and Dengue virus coinfection with heterozygous Beta Thalassemia

We report a 30-year-old man with hemoglobinopathies coinfected with SARS-CoV2 and Dengue virus from Bangladesh. Dengue virus was detected by ELISA. Covid-19 was confirmed by RT-PCR and Hemoglobin Electrophoresis revealed heterozygous beta-thalassemia. The patient was treated successfully at Dhaka Hospital in icddr,b during Covid-19 emergency response with symptomatic supportive treatment for Covid-19 and appropriate fluid therapy for dengue fever in response to daily hematocrit level. After 21 day, the patient’s RT-PCR for Covid-19 became negative. For thalassemia, the patient was advised to have genetic counseling and family screening on discharge. The data complies here were gathered from the patient management record file. The possibility of coinfection should be considered during the Dengue fever epidemic along with the confirmatory tests for Covid-19, when any alarming signs supporting possibility of dengue fever are found in an individual. Fluid therapy for dengue fever must be maintained with utmost care to avoid adverse effect from Covid-19-Dengue coinfection and careful monitoring of oxygen saturation during the sick period of this type of case should be performed with importance.